Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole

    • Product Name 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole
    • Alias Boc-D-Ala-D-Phg-OH
    • Einecs NA
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    330461

    Chemical Name 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole
    Molecular Formula C20H20N2O4S
    Molecular Weight 384.45 g/mol
    Appearance White to off-white solid
    Solubility Soluble in DMSO, slightly soluble in methanol
    Purity Typically ≥98%
    Storage Conditions Store at -20°C, protect from light and moisture
    Functional Groups Pyrrole, phenyl, sulfonamide, ester, amino acid derivative
    Optical Activity Chiral (contains L-alanine residue)
    Synonyms 3-[[(S)-2-(4-methylbenzenesulfonamido)propanoyl]oxy]-5-phenyl-1H-pyrrole
    Application Intermediate for organic synthesis and pharmaceutical research

    As an accredited 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass vial containing 1 gram of 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole, tightly sealed with a screw cap, labeled for research use.
    Shipping The chemical **3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole** is shipped in a tightly sealed container under ambient conditions, protected from moisture and light. Appropriate labeling and documentation are included, and packaging complies with relevant safety and regulatory requirements for laboratory chemicals to ensure safe transport and handling.
    Storage 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, ideally at 2–8°C (refrigerator). Avoid exposure to strong oxidizers, acids, and bases. Ensure proper labeling and restricted access. Always handle under appropriate laboratory safety protocols, including gloves and protective eyewear.
    Application of 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole

    Applications of 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole in Industrial Manufacturing

    As the original developer and primary manufacturer of 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole, we support a range of specialized applications within the pharmaceutical, chemical synthesis, and materials science sectors. This specialty raw material integrates into advanced downstream industrial processes, serving as a selective reagent, chiral auxiliary, and protected intermediate. The following sections detail its authentic industrial utilization, formulation requirements, and regulatory context in major application fields.

    1. Stereoselective Pharmaceutical Intermediate Synthesis

    Pharmaceutical ingredient manufacturers utilize this compound primarily as a stereochemical control element and a temporary protecting group in the multi-step synthesis of chiral active pharmaceutical ingredients (APIs). Its incorporation influences product purity and yield, particularly in enantioselective syntheses for next-generation medicines. Process chemists favor its role in introducing a protected alanine moiety while minimizing racemization and undesired by-products, supporting robust downstream isolation and purification steps.

    Industry compliance standards

    • Current Good Manufacturing Practice (cGMP, ICH Q7)
    • USP General Chapter <1078> on GMP for Bulk Pharmaceutical Chemicals
    • European Pharmacopoeia (Ph. Eur.) manufacturing quality control standards
    • U.S. FDA 21 CFR Part 211 (Finished Pharmaceuticals)

    Typical usage ratio

    • Batch molar ratio between 1.05:1 and 1.2:1 relative to target amino acid or amine substrate; adjusted based on API complexity and required optical purity.

    Downstream process integration

    • Introduced in early or intermediate steps during chiral building block assembly for API manufacturing, often followed by hydrogenation, hydrolysis, or deprotection to yield the target functional group set. Integrated into controlled reaction environments (e.g., inert atmosphere, temperature-specific reactors).

    Final product types

    • Enantiomerically pure pharmaceutical intermediates
    • Chiral APIs for oncology, antiviral, or CNS indications

    2. Peptidomimetic and Oligopeptide Research Scale-Up

    Peptide and peptidomimetic research facilities employ this material as a customizable protected amino acid derivative in solution-phase and solid-phase peptide synthesis (SPPS). Its tosyl-protected nitrogen limits side-reactions such as undesired acylation or cyclization during chain elongation and enables selective deprotection downstream. The controlled application improves the overall synthetic throughput for bioactive peptide candidates destined for clinical or commercial development.

    Industry compliance standards

    • International Conference on Harmonisation (ICH Q11) for API development
    • Syntheses according to European Pharmacopoeia Monograph 1468 and relevant local pharmacopeial guidelines
    • ISO 9001:2015-certified process documentation and traceability
    • FDA and EMA guidelines for research-grade peptide manufacturing

    Typical usage ratio

    • 0.95–1.10 equivalents per peptide coupling cycle; adjusted to ensure complete coupling and avoid excess unreacted reagent, depending on resin loading and chain length.

    Downstream process integration

    • Loaded onto resin or introduced during solution-phase assembly following standard Fmoc/t-Boc strategies; incorporated prior to chain extension steps requiring alanine insertion with specific protection profile. Deprotection typically follows assembly or at the desired elongation stage.

    Final product types

    • Oligopeptides and peptidomimetic libraries for drug discovery
    • Modified peptides for diagnostics and biochemical research

    3. Advanced Organic Synthesis of Heterocyclic Building Blocks

    Specialty fine chemical producers leverage this intermediate in the formation of tailored heterocycles used in bioactive molecule discovery and agrochemical development. The pyrrole ring system, functionalized with a protected amino acid moiety, serves as a versatile precursor for generating complex heterocyclic frameworks under mild or stepwise conditions. Its application enables precise incorporation of chirality and functional handles in process development for structurally unique research chemicals or lead-like scaffolds.

    Industry compliance standards

    • ISO 9001:2015-certified production and process documentation
    • Responsible Care® chemical management systems
    • REACH Regulation (EC) No 1907/2006—registration and safety standards for substance production within the EU
    • Internal QC protocols for process development and reference standards

    Typical usage ratio

    • Depending on target heterocycle, typically 1.0:1 with core reactant; may be increased to 1.2 equivalents when yield or conversion at scale is unsatisfactory.

    Downstream process integration

    • Charged at the cyclization or condensation stage after pre-activation of the heterocyclic nucleus; serves as the chiral nitrogen component in formation of functionalized pyrrole, indole, or other polycyclic systems.

    Final product types

    • Functionalized pyrroles, indoles, and fused heterocyclic keys for discovery chemistry
    • Active bioisosteres and scaffold molecules for medicinal and agrochemical research

    4. Manufacture of Chiral Ligands and Catalysts for Asymmetric Synthesis

    Producers of molecular catalysts and ligand systems for asymmetric synthesis select this compound as a precursor to chiral ligand frameworks, exploiting its protected alanine functionality to access enantiopure educts. It allows the tailored introduction of chiral handles onto nitrogen or carbon ligand backbones, supporting the creation of catalytic systems with reliable selectivity in downstream fine chemical and pharmaceutical processes.

    Industry compliance standards

    • ISO 9001:2015 manufacturing quality management
    • REACH registration and documentation requirements for new catalyst components
    • Internal analytical standards for chiral purity (HPLC/GC)
    • EU Regulation (EC) No 1272/2008 (CLP) for chemical classification and labeling

    Typical usage ratio

    • Equimolar ratio relative to the core ligand precursor; adjustments (0.9–1.2 equivalents) based on the degree of functionalization and catalyst loading demand in the targeted asymmetric reaction.

    Downstream process integration

    • Employed during the functionalization step of ligand synthesis, where it attaches to the desired site via amidation or ether formation prior to catalyst activation or metalation.

    Final product types

    • Chiral ligand libraries for asymmetric hydrogenation, epoxidation, or coupling reactions
    • Organometallic catalysts for industrial-scale chiral synthesis

    5. Protected Chiral Auxiliary Construction for Custom Synthesis Services

    Custom synthesis facilities utilize this compound as a protected chiral auxiliary in the creation of asymmetric intermediates for contract and toll manufacturing. The tosyl-L-alaninyloxy group enhances selectivity in stereochemistry-setting reactions that downstream clients require for their patented molecular structures, particularly when high-yield production of single-enantiomer intermediates is essential for competitive project timelines. Selective deprotection or group transformation later in the synthetic sequence ensures the intermediate achieves the necessary structural fidelity for subsequent coupling or elaboration.

    Industry compliance standards

    • Confidential cGMP manufacturing contracts (as per ICH Q7)
    • Dedicated process validation per client project (USP/NF, Ph. Eur. references where required)
    • ISO 13485 for intermediates entering medical device or diagnostic supply chains
    • Full batch traceability and lot retention as per client and regulatory protocols

    Typical usage ratio

    • Applied at 1.0 equivalent based on moles of prochiral substrate or acceptor; industry best practice adjusts up to 1.3 equivalents for higher stereochemical control in pilot to kilo-lab scale runs.

    Downstream process integration

    • Charged at the chirality-defining step, typically prior to downstream deprotection or further derivatization, ensuring high-fidelity transfer of stereochemical information throughout scale-up and isolation.

    Final product types

    • Single-enantiomer building blocks for pharmaceutical and biotech pipelines
    • Custom chiral intermediates supplied under contract for further synthesis
    Free Quote

    Competitive 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole: Precision by Design

    The Care and Craft Behind Specialized Heterocyclic Synthesis

    Working in chemical manufacturing, every new molecule we bring to life tells a story about problem-solving at the bench and balancing expectations throughout the production chain. The compound 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole emerged as a response to rising demand for fine-tuned heterocycles, especially among researchers tackling pharmaceutical and advanced material challenges.

    We designed this pyrrole derivative with a deep understanding of its target applications—particularly in fields requiring chirality, functional group compatibility, and reliable performance in downstream transformations. Our in-house team, led by chemists who spend weeks refining reaction conditions, took a close look at fragment choices and their synthetic accessibility. Each batch draws from a decade of scale-up experience and lessons learned about avoiding side-products, keeping impurities at bay, and maintaining batch-to-batch reproducibility.

    From Theory to Bench: Why This Molecule?

    The world rarely sees what happens between an idea and a kilogram of product sealed for shipment. For us, the journey started with a need for a new chiral auxiliary: something robust, with tunable reactivity and defined stereochemistry. We focused on the N-tosyl-L-alaninyloxy group because it brings strong, reliable asymmetric induction and controls further transformations. By coupling this with a 5-phenylpyrrole core, our chemists amplified both solubility and electronic versatility, opening doors to coupling reactions and functionalizations that fail with simpler pyrroles.

    Specifications Rooted in Practice

    Our process keeps impurities low. We use a multi-step synthetic route that has been stress-tested repeatedly for industrial relevance. Handcrafted crystallization protocols yield pure product, free from regioisomeric or diastereomeric confusion. The choice of solvents, reagents, and purification steps wasn’t theoretical—extensive pilot runs flagged hidden incompatibilities and led us to select pathways allowing for straightforward upscaling and tighter process control. Regular NMR and chiral HPLC monitoring prove out stereopurity, and we never release a drum without batch data archived and samples double-checked.

    This molecule exits our reactors as a solid, not an oil or unstable intermediate. The melting point and stability over months in ambient conditions enable direct delivery to labs and production lines across seasons and shipping routes. Our dry finishing steps leave no residual solvents that could interfere with target reactions or leave behind regulatory headaches.

    The Role in Modern Synthesis

    From where we stand at the reactor floor, 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole serves as more than just a building block—it reduces the cost and complexity of downstream chemistry. Pharmaceutical researchers appreciate the stereochemically defined backbone. They know this molecule can serve as a chiral auxiliary, guiding enantioselective synthesis of beta-lactams, polypeptides, or other valuable frameworks. Material scientists look to it for its balanced reactivity and clean deprotection profile, allowing them to assemble advanced conjugated systems, sensors, or photoreactive surfaces without the headaches associated with less stable auxiliaries.

    Colleagues in peptide and oligonucleotide research prefer this to bulkier auxiliaries that drag down yields or increase purification headaches. By sticking with L-alanine’s small side chain and the electron-withdrawing effect of the tosyl group, their couplings run cleaner, and they spend less time troubleshooting side-reactions. We’ve heard from early adopters how moving to our product helped eliminate tedious column purifications and batch rejection due to impurity carryover.

    Differences That Matter: Why Choose This Derivative?

    Customers tend to ask, “Can’t you just use a plain pyrrole or a simpler N-acylated derivative?” Decades in process chemistry say otherwise. Ordinary 5-phenylpyrrole lacks enantiopurity and doesn’t offer control in stereodriven reactions. Other N-acyl heterocycles sometimes hydrolyze too readily or add unnecessary bulk, complicating purification and downstream cleavage. Our derivative, built on the L-alanine frame, delivers both the right size for selectivity and the synthetic robustness to withstand typical peptide-bond formation conditions. The tosyl protecting group brings just the right level of stability—visible in side-by-side hydrolysis studies we shared with key clients. It sets a tight window for deprotection, so their workflow isn’t stalled by tricky removal steps.

    Looking back at years of troubleshooting, we recall projects derailed by unpredictability in unrefined pyrrole sources. Unwanted isomerism, inconsistent loading, and demand for extra clean-up pushed us to ignore “commodity” style solutions. By keeping control over chirality, intermediate purity, and final crystallinity, we offer more value. Lab teams waste less material, lose less time, and report cleaner analytics.

    Supporting Innovation With Real Experience

    Over the course of multiple campaigns, it became clear that real-world reliability comes from more than theoretical purity. We regularly batch product with focus on tight particle size control, low moisture content, and packaging built for dusty or humid environments. We learned firsthand that a solid block of “high purity” material that clumps in the drum is as frustrating as contaminated product. By consulting with both scale-up engineers and application chemists, we adopted anti-caking measures without resorting to unknown additives or performance enhancers.

    We also know that researchers and formulators test stability and batch consistency with a rigor matching our own. We keep an open feedback line; a Boston biotech flagged a subtle yellowing after several weeks in their solvent, which prompted us to tweak our drying cycle and swap out an older filtration medium. Since then, both visual color and NMR purity checks have held up. The difference between bench chemistry and plant reality shows up in these small, iterative process improvements.

    Practical Use Cases: Where Time and Purity Count

    Our regular partners in medicinal chemistry teams aren’t only looking for a source of chiral pyrrole—they want to predict how reactions behave days or months down the line. This molecule serves them well in multi-step chiral auxiliary strategies due to straightforward protection and deprotection, and the stability of its derived intermediates in open air. Many run syntheses that require extended exposure to mild heating or basic environments; batch results consistently report no byproduct formation, minimizing cleanup demands. In total synthesis campaigns, predictable removal of the tosyl group under mild acidic or reductive conditions adds assurance that library diversification or scale-up won’t introduce unexpected complications.

    Process development teams point out the benefits of reduced processing time. The ability to take this product from shipping drum to reaction flask, without repeated pre-washes or pre-activation, slashes setup effort and helps keep project timelines steady. Such hands-on details have grown in importance as more companies face shorter cycle times for candidate development and custom molecule production.

    Driving Down Costs: Efficiency Through Focus

    Any lab manager or plant engineer putting together cost projections will notice quickly that cheaper starting materials sometimes balloon total spend during troubleshooting. We keep totals down with lower purification costs, fewer failed runs, and less batch-to-batch analytical rework. Every time a partner shares savings from eliminating extra column runs or solvent rinses, we’re reminded that design up front rewards everyone along the chain.

    For larger campaigns, each kilogram arriving with tight quality documentation and repeatable properties spares days of QC and approval cycles. We’ve seen direct savings in both labor hours and wasted product—all traceable to consistent engineering choices at the molecule and process level.

    Real-World Challenges: Chemical Handling With Confidence

    Operational experience goes beyond published procedures. Process design often overlooks how a compound behaves during storage or long-term handling. Our product tolerates variable shipping climates without degradation. We had a shipment held up during customs inspection over a hot summer, and the recovered batch still matched fresh product purity—no decomposition, no loss of crystallinity.

    Some users noticed that traditional pyrrole auxiliaries tended to oxidize or discolor after repeat flask openings, creating periodic reordering headaches. Our choice of crystalline form and inert packaging has sharply reduced reports of such incidents. These small improvements translate to fewer supply-chain interruptions and less bench-level frustration.

    Environmental Thoughtfulness in Manufacturing

    Increasing regulatory focus on both footprint reduction and chemical lifecycle was already top of mind during product design. Our manufacturing protocol pivots away from high-waste, chlorinated solvents. We reclaim and recycle wash streams, reducing the per-kilogram environmental impact. We substituted older, more hazardous reagents after trials proved alternatives delivered equivalent—but less environmentally risky—results.

    Colleagues in green chemistry frequently assess every new product arriving at their sites. Hearing that a product originates from a cleaner process means real cost and compliance savings when audits roll around. We’re upfront on solvent, waste, and reagent profiles, sharing our findings with any customer managing their own environmental reporting. The push for cleaner science starts well before the molecule leaves our reactors.

    No Substitute for First-Hand Experience

    There’s a temptation across the industry to focus on theoretical benefits or textbook protocols. In our view, product value grows from continuous hands-on improvement, collaboration with early users, and readiness to address issues without delay. Each inquiry teaches us something new—often as much about logistics or handling as about chemistry itself.

    A recent feedback loop with a European research group led to minor but crucial tweaks: better seal liners, extra dryness control, and batch-by-batch open reporting of any visible crystal habit changes. The impact was immediate—a drop in QC rejections and an uptick in successful, reproducible syntheses on their side. No top-down guideline could have predicted these details; they come from real people solving real problems, day by day.

    Outlook: Setting the Standard for Heterocyclic Customization

    We recognize this product doesn’t fit every synthetic need. Routine large-scale commodity projects may not require the added value of stereopurity, or the tailored balance of reactivity and stability that defines our 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole. For those who do—for the innovators pushing molecular complexity, who can’t afford random variables or unnecessary troubleshooting—this derivative has proven its worth.

    As fields pivot toward even more demanding synthesis—think new small-molecule drugs, next-generation organic electronics, or multi-functional materials—reliability in source materials pays dividends at every step. Our commitment remains shaped by seeing chemical innovation from every angle: the process-scale engineer, the discovery chemist, and the pilot plant operator. Each new batch incorporates lessons from the field, not just the textbook.

    Choosing the right heterocycle isn’t a matter of just picking from a catalog. We contribute the perspective and know-how of a manufacturer who’s seen the difference between theory and practice. Our hope is that chemists choosing 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole for their next project will feel that every detail—from crystal to case study—reflects decades of earned experience and a genuine partnership in the pursuit of better chemistry.